Eurofins: Q3 sales up 22%
(CercleFinance.com) - Eurofins Scientific has posted Q3 2019 sales of 1,167 million euros, up 22.
3% as reported and up 6.4% in organic terms
(+7.3% excluding Boston Heart Diagnostics).
The bio-analyticsal services provider says that its teams have worked hard to fully recover from the cyber-attack on 2 June, and have further strengthened their IT systems.
"We remain confident on our ability to achieve our objectives for this and next year," said CEO Gilles Martin, adding that, "By the end of 2020, this exceptional investment phase started in 2016 will largely be completed".
Copyright (c) 2019 CercleFinance.com. All rights reserved.
3% as reported and up 6.4% in organic terms
(+7.3% excluding Boston Heart Diagnostics).
The bio-analyticsal services provider says that its teams have worked hard to fully recover from the cyber-attack on 2 June, and have further strengthened their IT systems.
"We remain confident on our ability to achieve our objectives for this and next year," said CEO Gilles Martin, adding that, "By the end of 2020, this exceptional investment phase started in 2016 will largely be completed".
Copyright (c) 2019 CercleFinance.com. All rights reserved.